Light Mode
$0.0461 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0461, and at the day’s high of $0.0470
-0.03 (-36.85%) / 6M
Momentum, market sentiment, and recent alerts
RDGL reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -42.9%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Vivos, Inc. is a radiation oncology medical device company. It is engaged in the development of its yttrium-90 based brachytherapy device, RadioGel, for the treatment of non-resectable tumors. Its product, RadioGel, is an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals. The company was founded by James C. Katzaroff on December 23, 1994 and is headquartered in Kennewick, WA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.